MoonLake Immunotherapeutics
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy MoonLake Immunotherapeutics stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for MoonLake Immunotherapeutics by name or ticker, choose the number of shares, and place your order.
The ticker symbol for MoonLake Immunotherapeutics is MLTX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
MoonLake Immunotherapeutics has its primary listing on NASDAQ (Small cap). You can trade MoonLake Immunotherapeutics with a Saxo account, alongside thousands of other stocks worldwide.
Yes, MoonLake Immunotherapeutics is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include MoonLake Immunotherapeutics as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like MoonLake Immunotherapeutics.